- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2018-03-21
DOI
10.1093/jnci/djy067
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HER kinase inhibition in patients with HER2- and HER3-mutant cancers
- (2018) David M. Hyman et al. NATURE
- Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG 1406).
- (2017) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer
- (2017) John H. Strickler et al. Cancer Discovery
- Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer
- (2016) W.-J. Zuo et al. CLINICAL CANCER RESEARCH
- Targeted therapy for gastrointestinaI (GI) tumors based on molecular profiles: Early results from MyPathway, an open-label phase IIa basket study in patients with advanced solid tumors.
- (2016) Herbert Hurwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials
- (2016) Susan D Richman et al. JOURNAL OF PATHOLOGY
- Targeted molecular profiling of rare genetic alterations in colorectal cancer using next-generation sequencing
- (2016) Mayank Jauhri et al. MEDICAL ONCOLOGY
- MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a de novo phenomenon
- (2016) Kanwal Raghav et al. Oncotarget
- PIK3CA Mutations Are Associated With Decreased Benefit to Neoadjuvant Human Epidermal Growth Factor Receptor 2–Targeted Therapies in Breast Cancer
- (2015) Ian J. Majewski et al. JOURNAL OF CLINICAL ONCOLOGY
- Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials
- (2015) Funda Meric-Bernstam et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutations in the Kinase Domain of the HER2/ERBB2 Gene Identified in a Wide Variety of Human Cancers
- (2015) Wenhsiang Wen et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Mutational and expressional analysis ofERBB3gene in common solid cancers
- (2014) Mi Ryoung Choi et al. APMIS
- Oncogenic ERBB3 Mutations in Human Cancers
- (2013) Bijay S. Jaiswal et al. CANCER CELL
- PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and Survival
- (2013) Christophe Rosty et al. PLoS One
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- A Molecularly Annotated Platform of Patient-Derived Xenografts ("Xenopatients") Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
- (2011) A. Bertotti et al. Cancer Discovery
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started